MedX Health Corp Stock

Equities

MDX

CA5850901037

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 03:03:38 2024-05-23 pm EDT 5-day change 1st Jan Change
0.08 CAD -11.11% Intraday chart for MedX Health Corp -5.88% +33.33%
Sales 2022 511K 373K Sales 2023 456K 334K Capitalization 15.72M 11.5M
Net income 2022 -5M -3.66M Net income 2023 -4M -2.93M EV / Sales 2022 22.1 x
Net Debt 2022 4.86M 3.55M Net Debt 2023 5.71M 4.17M EV / Sales 2023 47 x
P/E ratio 2022
-1.25 x
P/E ratio 2023
-2.58 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 93.59%
More Fundamentals * Assessed data
Dynamic Chart
1 day-11.11%
1 week-5.88%
Current month-11.11%
1 month-11.11%
3 months+166.67%
6 months+33.33%
Current year+33.33%
More quotes
1 week
0.07
Extreme 0.07
0.09
1 month
0.07
Extreme 0.07
0.10
Current year
0.03
Extreme 0.025
0.11
1 year
0.03
Extreme 0.025
0.11
3 years
0.02
Extreme 0.02
0.17
5 years
0.02
Extreme 0.02
0.26
10 years
0.02
Extreme 0.02
0.33
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-24
Director of Finance/CFO - 22-04-28
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 84 01-11-18
Chairman - 01-11-18
Chief Executive Officer - 23-04-24
More insiders
Date Price Change Volume
24-05-23 0.08 -11.11% 260,000
24-05-22 0.09 +5.88% 174,750
24-05-21 0.085 0.00% 52,764
24-05-17 0.085 +6.25% 246,000
24-05-16 0.08 0.00% 10,000

Delayed Quote Toronto S.E., May 23, 2024 at 03:03 pm EDT

More quotes
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
More about the company